Entera Bio Ltd. - Ordinary Shares, par value per share NIS 0.0000769 (ENTX)

CUSIP: M40527109

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 7 signals
Share change
+2,728,036
Put/Call ratio
0.32%
SEC-reported price per share
$1.70
Number of holders
18
Value change
+$4,637,662
Number of buys
8
Open additional details 1 more signal available
Number of sells
3
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
170,503,000

Security key

M40527109

Report period

Q1 2025

Institutions

18

Top holders

10

Ownership snapshot

Top reported holders of ENTX - Entera Bio Ltd. - Ordinary Shares, par value per share NIS 0.0000769 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
OPKO HEALTH, INC.
Disclosed value leader
Knoll Capital Management,...
Comparable rows
15/15
Latest evidence
16 Mar 2025
13D/G 13F 3/4/5 Lead comparable stake: 8.1% 13D/G row: OPKO HEALTH, INC. Showing 1-6 of 15 holder rows.

Quick read

OPKO HEALTH, INC. leads the comparable SEC ownership view at 8.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens OPKO HEALTH, INC.'s linked filing trail.
Comparable ownership Top 5
OPKO HEALTH, INC. 8.1%
Knoll Capital Management, LLC 3.4%
Schonfeld Strategic Advisors LLC 0.37%
Parkman Healthcare Partners LLC 0.24%
NORTHERN TRUST CORP 0.12%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
OPKO HEALTH, INC.
13D/G
8.1%
$8,660,281
3,685,226 shares
$0 16 Mar 2025
Knoll Capital Management, LLC
13F 3/4/5
Company · 10%+ Owner
3.4%
$12,469,583
5,881,879 shares
31 Dec 2024
Schonfeld Strategic Advisors LLC
13F
Company
13F
0.37%
$1,340,499
632,311 shares
31 Dec 2024
Parkman Healthcare Partners LLC
13F
Company
13F
0.24%
$877,112
413,732 shares
31 Dec 2024
NORTHERN TRUST CORP
13F
Company
13F
0.12%
$450,464
212,483 shares
31 Dec 2024
Perigon Wealth Management, LLC
13F
Company
13F
0.09%
$325,230
145,843 shares
31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
18
Shares
10,222,258
Rows available
18
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2026 Across Filers

Q1 2026 holders
26
Q1 2025 holders
18
Holder diff
-8
Investor Q1 2026 Shares Q1 2025 Shares Share Diff Share Chg % Q1 2026 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .